MAGE family member A7, pseudogene (MAGEA7P)

MAGE family member A7, pseudogene (MAGEA7P) is a non-coding DNA sequence classified as a pseudogene of the MAGE-A subfamily, itself part of the melanoma-associated antigen (MAGE) family, a class of cancer/testis antigens mainly expressed in germ cells and various tumors[1][2][3]. MAGEA7P does not produce a functional protein and has no direct biological or pathological function described in the literature[1][3]. It is not considered a therapeutic target, nor is it associated with a specific disease role, drug interactions, or mechanistic actions. Importantly, MAGEA7P should not be confused with protein-coding MAGE-A family members such as MAGE-A3 or MAGE-A4, which are the actual focus of cancer immunotherapy research[2][3][4]. The inclusion of “pseudogene” in the name underscores that this is not a functional gene, nor is it a validated therapeutic or diagnostic target. The designation as “pseudogene” means that this locus cannot be targeted directly for therapeutic intervention, nor does it produce an active protein product; references to disease relevance or druggability instead apply to its protein-coding relatives in the MAGE-A family[1][3][4]. Queries for “MAGEA7P” as a target for drugs or biomarkers are therefore technically incorrect; in oncology and immunology, only the functional MAGE-A genes are relevant for these applications[3][4].

Other names

MAGEA7PMAGE family member A7, pseudogene